Salipro invited to speak at GPCRs-Targeted Drug Discovery Summit

New data revealed! Our CSO Robin Löving is an invited speaker at the GPCRs-Targeted Drug Discovery Summit (March 22-24) and will for the first time be sharing cryoEM data of the Salipro®-CXCR4-CXCL12 complex from our collaboration with Thermo Fisher Scientific. Tune in to learn more!

GPCRs-Targeted Drug Discovery Summit event link

Previous
Previous

New study uses Salipro for anaesthesics research

Next
Next

Salipro presenting Oxford Global Biologics